CDR2 Products

Description

CDR2 suppresses the transcriptional activity and DNA binding of nuclear factor-kappa B by an unknown mechanism. The neuron specific expression of CDR-2 is regulated by a post-transcriptional mechanism. CDR2 antibodies are useful tools for transcription regulation and neurology.

Bioinformatics

Entrez	1039 Human 12585 Mouse
Uniprot	AAH17503 Human NM_001802 Human NP_001793 Human NP_001793.1 Human NP_006089 Human Q01850 Human
Product By Gene ID	1039
Alternate Names	CDR62 cerebellar degeneration-related protein (62kD) cerebellar degeneration-related protein 2 cerebellar degeneration-related protein 2, 62kDa Major Yo paraneoplastic antigen Paraneoplastic cerebellar degeneration-associated antigen PCD17 Yo paraneoplastic antigen Yo

Research Areas for CDR2

Find related products by research area and learn more about each of the different research areas below.

Cancer
Hypoxia
Immune System Diseases
Immunology
Neuroscience
Signal Transduction

Related CDR2 Blog Posts

Check out the latest blog posts on CDR2.

Cerebellar Degeneration-Related Protein 2 (CDR2): Cell-Cycle Regulated Tumor Antigen CDR2 is a tumor antigen expressed in a high percentage of breast and ovarian tumors and is the target of a naturally occurring tumor immune response in patients with paraneoplastic cerebellar degeneration. CDR2 has also been shown to be a cell cycle r...    Read more.

Read more CDR2 related blogs.